Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ABS Appoints Stamatis Fradelos Vice President of Regulatory Affairs

Industry Veteran to Spearhead ABS Engagement with Global Maritime Administrations and Regulatory Bodies (ATHENS) As shipowners navigate an ever more complex regulatory environment, ABS has appointed specialist Stamatis Fradelos as Vice President of Regulatory Affairs. Fradelos, who returns to ABS’ Athens office, where he was previously Business Director and member of the IACS Environmental Panel, will spearhead ABS engagement with administrations and regulatory bodies and support the industry with compliance guidance. “ABS is engaged with maritime regulators and

First patient randomized in pivotal TRANSFORM study with setanaxib

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the first patient has been randomized in the company’s pivotal phase 2b/3 TRANSFORM study in patients with primary biliary cholangitis (PBC).The TRANSFORM trial is a 52-week, randomized, placebo-controlled, double-blind, adaptive Phase 2b/3 trial. It will initially investigate the effect of setanaxib 1200 mg/day and 1600 mg/day versus placebo on alkaline phosphatase (ALP) reduction in patients with PBC and with elevated liver stiffness and intolerance or inadequate response to

Dignitana AB appoints Interim CFO

Dignitana AB has appointed Alf Christensson as Interim CFO of Dignitana. He will assume the role on 1 March, 2022. Alf Christensson has most recently been CFO of Salix Group, part of the Swedish industrial group Volati AB, which is listed on Nasdaq Stockholm in the Large Cap segment. He previously served as CFO of Välinge Group and held several leading roles in business and finance with Sony Ericsson. He has a B Sc. In Economics and Management from University of London and lives in Malmö.

SafeTeam wins the procurement – receives large order for digital locks from iLOQ

The security company SafeTeam has received a major order from Ekerö Bostäder after winning a public procurement during the autumn of 2021. The order has a value of just over SEK 5 million and concerns the digital locking system from iLOQ, which will now be installed in the entire Ekerö Bostäder apartment portfolio. The municipality has previously used the system in a limited number of residential buildings, but Ekerö Bostäder has now chosen to extend the system by installing it in all its apartments. Behind the decision was a desire to minimize the harmful impact of lost keys. "

Contract extension for CSV Normand Clipper with Global Marine Group

Solstad Offshore ASA and Global Marine Group have agreed to extend their present contract for the CSV Normand Clipper with further three years to May 2026, and additional options thereafter. Global Marine Group will continue to utilize the vessel to support their world-wide cable lay operations. The commercial terms and conditions are confidential between the parties. Skudeneshavn, February 15[th], 2022 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASAwww.solstad.com

Wärtsilä solutions open route to decarbonisation for Poland’s first LNG-fuelled RoPax vessels

Wärtsilä Corporation, Press release, 15 February 2022 at 10.30 AM EETThe technology group Wärtsilä has been contracted by Remontowa shipyard in Poland to supply engines, fuel storage and supply systems for three new RoPax vessels, the first LNG-fuelled RoPax vessels to be built for the Polish maritime sector. The ships will be operated by ferry companies Unity Line and Polferries. The contract with Wärtsilä was signed in January 2022. The vessels will each operate with four highly efficient Wärtsilä 31DF dual-fuel engines . The LNG-fuelled engines can use bio-

New shares of Nurminen Logistics Plc registered with the trade register

Nurminen Logistics Plc                 Stock exchange release February 15, 2022, at 10.30 am A total of 774 386 new shares (the “New Shares”) issued in Nurminen Logistics Plc’s (the “Company”) share issue to the Company itself without consideration has been registered with the Trade Register on February 15, 2022. Following the registration of the New Shares, the total number of the Company’s shares is 77 968 576 shares. The New Shares will be admitted to trading together with the Company’s existing shares on the official list of Nasdaq Helsinki Ltd on or about February 16, 2022.

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 41 - 15 FEBRUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

SAGA partners with MasterChef Finland

Metsä Tissue’s SAGA brand will be the official partner of MasterChef Finland in the spring of 2022. SAGA, which specialises in biodegradable and compostable paper products for baking and cooking, makes products for both consumer markets and professional kitchens.“Cooperation with the MasterChef programme is ideal for SAGA. The well-known global programme format is all about high quality, and the competitors are supplied with the very best products. Our products meet the criteria of both professionals and demanding home cooks, and it will be exciting to see how the competitors tackle all the

MPC Container Ships joins Mærsk Mc-Kinney Møller Center for Zero Carbon Shipping as an official supporter

MPC Container Ships ASA and Mærsk Mc-Kinney Møller Center for Zero Carbon Shipping have signed a project support agreement making MPC Container Ships ASA an official supporter to the Center. MPC Container Ships ASA will contribute to the Center work with market analysis capabilities building industry insight and strategic industry and policy recommendations focusing on the decarbonization of the maritime sector. MPC Container Ships ASA and its partner companies from the MPC Group are committed to provide further support to the Center hereby using its broad network and expertise in

IMD - Institut für Medizinische Diagnostik launches the GA-map® Microbiome Test in Germany

OSLO, NORWAY/BERLIN, GERMANY – 15 February 2022: Microbiome DX company Genetic Analysis AS (“GA”) and Institut für Medizinische Diagnostik (“IMD”), a part of the Medicover Group, announces today that IMD has launched the GA-map® Dysbiosis Test in Germany. IMD will activate its new Microbiome laboratory in February 2022 and add standardized microbiota testing to its existing test portfolio of products. This new Microbiota test offering will be marketed to customers in Germany and Europe.In 2021, Genetic Analysis launched the updated version of GA-map[®] Dysbiosis Test – the first CE-marked

Exercise of employee share options in Atea ASA ("the Company")

Reference is made to the stock announcement dated 9 February 2022.The share capital increase has been registered by the Norwegian Register ofBusiness Enterprises (Foretaksregisteret), and Atea's Articles of associationhave been revised accordingly.This information is subject of the disclosure requirements acc. to §5-12 vphl(Norwegian Trading Act). For further information, please contact: Robert Giori, CFO Atea ASA, mobile (+47) 934 09 188Ole Johan Fjellestad, Group Chief Accountant Atea ASA, mobile (+47) 992 74 829

Assemblin develops and expands its offer in the area of cooling technology

New energy and environmental requirements mean that cooling is a growth area in installation technology. Already highly competent in the area, Assemblin is now investing in becoming one of leading cooling installers in Sweden.Over recent years, climate change and new statutory requirements have focused attention on cooling and heat pump technology. This includes the Swedish Ordinance concerning certain fluorinated greenhouse gases (SFS 2016:1128), which entered into force in 2017 to supplement the EU fluorinated greenhouse gases regulation. The ordinance requires us, as an installation and

Pottermore and Storytel make multi-language production of the Hogwarts Library books

Pottermore and Storytel will work together to produce and distribute the Harry Potter series called the Hogwarts Library books in several new languages. The collection contains three stories: Fantastic Beasts and Where to Find Them, Quidditch Through the Ages and The Tales of Beedle the Bard.Since 2016, Storytel has been cooperating with Pottermore to distribute the Harry Potter series for subscribers all over the world. Now Storytel and Pottermore take their next step together by producing the Hogwarts Library books for audio. The productions will be released in ten different languages,

Invitation to Saab’s Sensor Seminar: Sensors - for a Safer World

Saab is pleased to invite media, financial analysts and investors to our Sensor Seminar, on 24th February 2022, 14:00 CET.The Sensor Seminar will be hosted by Carl-Johan Bergholm, Head of Saab´s business area Surveillance. The seminar will provide an insight on the journey to meet and counter the threats and challenges of modern warfare. This year’s seminar will demonstrate Saab’s take on current sensor development for today’s defence forces, on electronic warfare in a multi-domain environment and on how to get the deceptive advantage with electronic attack capabilities. We will also

NEW RECOMMENDATION BY THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION: All patients with suspected gastritis should be examined by Pepsinogen I, Pepsinogen II and Gastrin-17 biomarkers.

Biohit Oyj press release                                 15.2.2022 at 10.00 local time (EEST) In December 2021, the Ministry of Health of the Russian Federation made public new official clinical guidelines on the diagnostic practices to be followed for all patients with suspected gastritis or duodenitis (1). According to these new guidelines, “all patients with suspected precancerous changes in the stomach with gastritis (atrophy, intestinal metaplasia) in order to confirm the diagnosis, assess the risk of developing gastric cancer and determine the order of endoscopic observation is

Outokumpu receives the highest Platinum level sustainability recognition from EcoVadis

Outokumpu OyjPress releaseFebruary 15, 2022 at 10.00 EETOutokumpu receives the highest Platinum level sustainability recognition from EcoVadis Outokumpu has received the highest Platinum level recognition for the second year in a row from the sustainability rating platform EcoVadis. The Platinum level rating indicates that Outokumpu is among the top 1% of the over 85,000 companies evaluated. “We are happy to continue on the highest Platinum level in the EcoVadis rating and to be among the top 1% sustainability performers. We have made good progress in sustainability and launched

SMART WIRES OUTPERFORMS FULL-YEAR 2021 REVENUE, TRIPLING GROWTH FROM 2020

· Full-year 2021 revenue of approximately $47.5 Million; >3x growth over 2020; exceeds guidance of $38 to $42 million · Fourth quarter 2021 revenue of approximately $19.2 Million · Company issues 2022 revenue guidance in the range of $65M - $70MSmart Wires Technology Ltd. (NASDAQ 1[st] North: GOGRID-SDB.ST), a global power technology company that is advancing the delivery of affordable, clean electricity worldwide today announced its fourth quarter and 2021 full-year revenue results and issued 2022 revenue guidance. Fourth Quarter and 2021 Revenue Preliminary, unaudited fourth

BioStock: Aptahem’s Q4 lays groundwork for clinical studies

During the last quarter of 2021, Aptahem took further steps towards being able to initiate phase I clinical studies with the drug candidate Apta-1 in 2022, primarily by initiating production of GMP-certified drug substance. At the beginning of January, this was followed up by a signed start up agreement with an international clinical contract research organisation for the clinical development phase.Read the full article at biostock.se: https://www.biostock.se/en/2022/02/aptahems-q4-lays-groundwork-for-clinical-studies/ This is a press release from BioStock - Connecting Innovation &

BioStock: BiBBInstruments kicks off 2022 with capital raise

After reaching a key clinical milestone with EndoDrill Model X in deep tumours of the upper gastrointestinal tract at the end of 2021, BiBBInstruments is looking to expand its clinical programme into both existing and new cancer indications in 2022. In preparations for this, the company has announced raising 21.6 MSEK in a directed share issue. BioStock spoke with BiBB’s CEO Fredrik Lindblad to get his thoughts.Read the full interview with BiBBInstrument's CEO Fredrik Lindblad at biostock.se: https://www.biostock.se/en/2022/02/bibbinstruments-kicks-off-2022-with-capital-raise/ This is

Hynion AS 2021 Annual report

“2021 was a breakthrough year for Hynion. We raised capital, listed on Euronext Growth, explored exciting next-generation technologies and started expanding our station network. Our project pipeline supports our target of eight stations in Norway and Sweden by the end of 2022, followed by further expansion in Scandinavia and Europe.  We have in 2021 become the leading hydrogen refueler in Norway and Sweden,” says Ulf Hafseld, CEO of HynionSignificant events during the financial year Hynion is delivering on station development and volumes are increasing · Hynion has four established

Sleep Cycle year end report 2021: Increased net sales and new product launches

Net sales increased 15.0% to SEK 48.0m during the fourth quarter, corresponding to a 21.7% currency adjusted growth rate. During the quarter several new features were launched which, in combination with effective campaigns, lead to positive sales development. The total amount of subscriptions increased 14.3% to 901k. The subscription growth rate increased compared to last year (10.1%) but, due to negative foreign exchange impact, the volume growth was not fully reflected in revenues.Fourth quarter summary (October-December 2021) · Net sales increased by 15.0 % (23.0 % October-December

2021 Year-end report

A strong finish sums up a successful year With an order intake on par with Alelion's previous record year, we are showing that the long-term effort to transform the business is paying off. We enter the new year with a total order backlog amounting to MSEK 138. During the fourth quarter, order intake increased to MSEK 57, which allows us to sum up 2021 as one of Alelion's best years ever with an order intake totaling MSEK 184.The fouth quarter 2021 in brief · Net sales increased to MSEK 9.3 (8.5) · Order intake increased to MSEK 57.0 (1.8) · Operating costs for personnel, other

MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2021

Significant progress, both in the clinical program and in our business developmentOctober – December Financial summary for the quarter · Net turnover amounted to SEK 13.9 (1.5) million. · The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -23.5 (-10.6) million. Basic and diluted earnings per share amounted to SEK -0.44 (-0.46) and SEK -0.44 (-0.46) respectively. · Cash flow from operating activities amounted to SEK -5.4 (-1.0) million. · Liquid assets and short-term investments at the end of the period amounted to SEK 221.2 (70.0) million.

There are no items matching the current filter
There are no more items matching the current filter
Back to top